oxybutynin has been researched along with Bone Loss, Perimenopausal in 1 studies
oxybutynin: RN given refers to parent cpd
oxybutynin : A racemate comprising equimolar amounts of (R)-oxybutynin and esoxybutynin. An antispasmodic used for the treatment of overactive bladder.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bertonazzi, A | 1 |
| Nelson, B | 1 |
| Salvador, J | 1 |
| Umland, E | 1 |
1 review available for oxybutynin and Bone Loss, Perimenopausal
| Article | Year |
|---|---|
The smallest available estradiol transdermal patch: a new treatment option for the prevention of postmenopausal osteoporosis.
Topics: Bone Density; Estradiol; Estrogen Replacement Therapy; Female; Humans; Osteoporosis, Postmenopausal; | 2015 |